Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02052505
Other study ID # ALS01
Secondary ID
Status Completed
Phase N/A
First received January 29, 2014
Last updated January 4, 2017
Start date October 2014
Est. completion date July 2015

Study information

Verified date January 2017
Source Aalborg University
Contact n/a
Is FDA regulated No
Health authority Denmark: National Board of HealthDenmark: Danish Dataprotection Agency
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the effect of nurse-led medication reviews on the frequency, type and potential severity of PIP in psychiatric patients


Description:

Studies indicate that potential inappropriate prescribing (PIP) is associated with a higher number of admissions, increased morbidity and mortality and that medication reviews might decrease the prevalence of PIP. PIP has only been investigated in elderly populations and, to our knowledge, never in a psychiatric, general population. There is a growing body of evidence on the effect of medication reviews but very little research on the effect of medication reviews in psychiatric populations. Medication reviews are a time consuming task which requires an extensive clinical knowledge about the individual patient as well as pharmacology. Healthcare systems across the world are looking to improve quality and safety for the same or fewer economic resources and medication reviews are introduced as obligatory in more and more hospitals and other institutions. This calls for alternative use of existing resources.

Nurses have most of the direct patient contact but very few studies investigate the potential role of nurses in improving medication quality and medication safety. Administration af drugs and observation for effect and sideeffects of drugs are already important aspects in nursing. Therefore the purpose of this study is to evaluate the effect of nurse-led medication reviews in a controlled interventional study. Outcome measures include prevalence, type and severity of the identified PIP as well as the proportion of identified PIP which leads to a change in prescription by a physician.

Definitions

In this study PIP is defined as

- The use of drugs with a known risk of en adverse drug event or where evidence for a less risky, equally or more effective drug treating the same condition exists.

- PIP includes the use of drugs with a higher frequency or longer duration than indicated, concurrent use of drugs with known drug-drug interactions or interaction between drug and the underlying disease.

- PIP also includes the omission of drugs which are clinically indicated and where no contraindications are known.

Design

Prospective, controlled before- and after study where 2 acute psychiatric wards have been selected for intervention and control. Ahead of the intervention the nurses have received pharmacological training and instructions on performing medication reviews. The patients are included consecutively.

Data

The nurses in the interventional ward will perform medication reviews after the patients have been seen by the attending physician and thus have received usual care. This procedure was chosen because most of the patients are admitted through one ward. With each medication review the nurses fill out a structured paper form with their observations. The nurses also register whether interventions by the physician were based - or in parts based - on the nurses observations

Data analysis

Primary outcome is the difference in the proportion of patients receiving PIPs in the two wards. Two senior clinical pharmacologists will also perform medication reviews on the included patients. These medication reviews will serve as golden standard when the quality of the nurse-led medication reviews is evaluated.

Secondary outcomes will be an analysis of the proportion of PIPs identified by nurses and the proportion of PIPs ending in an intervention prescribed by a physician.

Power calculations

The investigators anticipate a prevalence of PIP on 30% among psychiatric patients and an expectation of a reduction to 15% PIP due to nurse-led medication reviews. Based on these assumptions there will be a need for 120 patients in each group in order to sufficiently identify a difference (risk of type 1 error - 5% and a power of 80%)


Recruitment information / eligibility

Status Completed
Enrollment 411
Est. completion date July 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- admitted to one of the included psychiatric wards

- must be over 18 years

Exclusion Criteria:

- concurrent admission to a somatic ward

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Procedure:
Medication review
The medication review will be based on the nurses experience, clinical knowledge and predefined categories of inappropriate prescribing

Locations

Country Name City State
Denmark Aalborg University Hospital Psychiatry Aalborg
Denmark Psychiatry, Aalborg University Hospital Aalborg

Sponsors (4)

Lead Sponsor Collaborator
Aalborg University Aalborg Universitetshospital, Danish Center for Healthcare Improvement, University College of North Jutland, The Nursing Department

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Assessment of type and severity of identified inappropriate prescriptions up to 1 week after admission Yes
Primary Estimation of potential difference in mean number of PIPs when applying nurses' observations within the first 3 days after admission Yes
Primary The potential difference in patients receiving = 1 PIP when applying nurses' observations within the first 3 days after admission Yes
Secondary Prevalence and types of PIP where physicians responded to nurses' observations and changed medicationsintervention by a physician within the first 3 days after admission Yes
See also
  Status Clinical Trial Phase
Completed NCT03688542 - Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module N/A
Completed NCT02545257 - Development of a Coordinated, Community-Based Medication Management Model for Home-Dwelling Aged in Primary Care N/A
Completed NCT03655405 - Randomised, Controlled Trial of an Individual Deprescribing Intervention for Nursing Homes Residents N/A
Recruiting NCT06437444 - Asthma Crisis in Paediatrics: Impact of a Care Pathway in Primary and Hospital Care N/A
Active, not recruiting NCT04022850 - De-implementation of Low-value Pharmacological Prescriptions N/A
Completed NCT04294901 - Engaging Patients to Promote Deprescribing N/A
Recruiting NCT03501108 - Discontinuation of Long-term Medications in Older People Entering Nursing Home Care N/A
Enrolling by invitation NCT03689049 - SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients N/A
Completed NCT02435290 - Enhancement of the Prediction of Chemotherapy Prescribing Errors for Oncology Patients N/A
Completed NCT03539276 - An Intervention to Reduce Inappropriate Medications in Long-term Care Residents With Severe Dementia N/A
Active, not recruiting NCT02744963 - Carefully seLected and Easily Accessible at No Charge Medications N/A
Recruiting NCT05875623 - Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults N/A
Completed NCT04586595 - A Randomised Pilot Study of the REVISiT Intervention N/A
Completed NCT03245879 - Antibiotic Stewardship in Small Hospitals N/A
Not yet recruiting NCT06129474 - Deprescribing Inappropriate Proton Pump Inhibitors N/A
Completed NCT06209827 - Effectiveness of a Community Intervention in the Chronic Use of Benzodiazepines: (BENZOSTOPJUNTOS) N/A
Recruiting NCT04028583 - Tool for Inappropriate Prescription Evaluation: The TaIPE Study N/A
Completed NCT03254472 - Big Data Analysis of the Use of bIomarkers Concentration N/A
Completed NCT05454644 - Effectiveness of a Person-centred Prescription Model at the End of Life N/A
Completed NCT02918643 - Using a Mobile Application as a Support at the Prescription of Appropriate Medications for Elderly N/A